“We achieved annual revenue of £1bn for the first time, up 10% and up 4% in constant currency. Reaching this milestone is testament to the strength of our brand, our long-standing DOCS strategy and the hard work and dedication of our fantastic people globally. Direct to consumer is now more than half our revenue and the Dr. Martens brand remains strong with all key metrics either ahead of, or in line with, last year. In EMEA and Japan, where we executed our strategy well, performance was very good with encouraging momentum going into the new financial year.

“In America, against the backdrop of a challenging consumer environment, we made operational mistakes, such as the move to our LA Distribution Centre, and how we executed our marketing campaigns and ecommerce trading. We have undertaken detailed reviews to understand why these issues occurred and have begun to embed the lessons learned into the business. We are fixing the issues in America, including a significant strengthening of the team there, and returning America to good growth is our number one operational priority.

“We are focused on the successful execution of our proven DOCS strategy, which we will underpin with continued investment in the business and our people to support our increasing scale and capitalise on our iconic brand’s strength. The board retains its conviction in the strategy, long-term growth and cash generation of the business. It is therefore proposing to maintain the final dividend at 4.28p per share and will seek shareholder approval at the AGM to commence an initial share buyback programme of up to £50m.”

Kenny Wilson, Chief Executive Officer

Kenny Wilson, CEO

Product and Brand teach-in

Watch the webcast of our Product and Brand teach-in, which took place on Thursday 14th September 2023 at 13:30 BST.

 

Watch WEBCAST

Reports and publications archive

Date 14 Sep 2023
Title Product and brand teach-in
Presentation View
Webcast Watch
Read
Date 13 Jul 2023
Title AGM Trading Statement
Statement View(Statement)
Date 13 Jun 2023
Title FY23 Annual Report
Report View
View ESEF XHTML
Download ESEF ZIP
Date 01 Jun 2023
Title FY23 Results
Presentation View
Statement View(Statement)
Webcast Watch
Read
Date 14 Apr 2023
Title FY23 Q4 Update
Statement View(Statement)
Webcast Watch
Read
Date 19 Jan 2023
Title FY23 Q3 Trading Update
Statement View(Statement)
Webcast Watch
Read
Date 24 Nov 2022
Title FY23 H1 Results
Presentation View
Statement View(Statement)
Webcast Watch
Read
Date 14 Jul 2022
Title AGM Trading Update
Statement View(Statement)
Date 06 Jul 2022
Title Conversion Markets Teach-In
Presentation View
Webcast Watch
Read
Date 14 Jun 2022
Title FY22 Annual Report
Report View
View ESEF XHTML
Download ESEF ZIP
Date 14 Jun 2022
Title 2022 AGM Notice of Meeting
Report View
Date 01 Jun 2022
Title FY22 Results
Presentation View
Statement View(Statement)
Webcast Watch
Read
Link Visit
Date 27 Jan 2022
Title FY22 Q3 Trading Statement
Statement View(Statement)
Webcast Watch
Read
Date 09 Dec 2021
Title FY22 H1 Results
Presentation View
Statement View(Statement)
Webcast Watch
Read
Date 29 Jul 2021
Title FY22 Q1 Trading Statement
Statement View(Statement)
Date 01 Jul 2021
Title 2021 AGM Notice of Meeting
Report View
Date 01 Jul 2021
Title FY21 Annual Report
Report View
Date 17 Jun 2021
Title FY21 Results
Presentation View
Statement View(Statement)
Webcast Watch
Read